EU/3/18/2031

About

On 27 June 2018, orphan designation (EU/3/18/2031) was granted by the European Commission to Air Liquide Santé (International), France, for argon for the treatment of perinatal asphyxia.

Key facts

Active substance
Argon
Disease / condition
Treatment of perinatal asphyxia
Date of first decision
27/06/2018
Outcome
Positive
EU designation number
EU/3/18/2031

Review of designation

The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.

Sponsor's contact details

Air Liquide Santé (International)
75 quai d’Orsay
75007 Paris
France
Tel. +33 1 49 69 82 00
E-mail: contact-healthcare-alsi@airliquide.com

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

How useful was this page?

Add your rating